Gene · 537
Papers1,446
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,446
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Hypoglycemic agents and incidence of pancreatic cancer in diabetic patients: a meta-analysis. | Front Pharmacol | 2023 | 37497113 | PubTator, text mining | PubMed |
| Effects of multiple stressors on pancreatic human islets proteome reveal new insights into the pathways involved. | Proteomics | 2023 | 37489002 | PubTator, text mining | PubMed |
Emergent (branched bur-reed-Sparganium erectum L.) and submergent (river water-crowfoot-Ranunculus fluitans Wimm., 1841) aquatic plants as metal biosorbents under varying water pH conditions in laboratory conditions. | Environ Sci Pollut Res Int | 2023 | 37480537 | PubTator, text mining | PubMed |
| STAG2 inactivation reprograms glutamine metabolism of BRAF-mutant thyroid cancer cells. | Cell Death Dis | 2023 | 37479689 | PubTator, text mining | PubMed |
| Evaluation of PEN2-ATP6AP1 axis as an antiparasitic target for metformin based on phylogeny analysis and molecular docking. | Mol Biochem Parasitol | 2023 | 37473813 | PubTator, text mining | PubMed |
| Race between virus and inflammasomes: inhibition or escape, intervention and therapy. | Front Cell Infect Microbiol | 2023 | 37465759 | PubTator, text mining | PubMed |
| Structural and functional understanding of disease-associated mutations in V-ATPase subunit a1 and other isoforms. | Front Mol Neurosci | 2023 | 37465367 | PubTator, text mining | PubMed |
| Editorial: Targeted cancer therapies, from small molecules to antibodies, volume II. | Front Pharmacol | 2023 | 37456736 | PubTator, text mining | PubMed |
| Long-term follow-up in common variable immunodeficiency: the pediatric-onset and adult-onset landscape. | Front Pediatr | 2023 | 37435172 | PubTator, text mining | PubMed |
| C-H Bonds as Functional Groups: Simultaneous Generation of Multiple Stereocenters by Enantioselective Hydroxylation at Unactivated Tertiary C-H Bonds. | J Am Chem Soc | 2023 | 37431886 | PubTator, text mining | PubMed |
| TMEM106B is a receptor mediating ACE2-independent SARS-CoV-2 cell entry. | Cell | 2023 | 37421949 | PubTator, text mining | PubMed |
| Prognostic and immunological potential of PPM1G in lung adenocarcinoma. | Mol Med Rep | 2023 | 37387407 | PubTator, text mining | PubMed |
| Expression of Connexin 43 in Granular Cell Tumors of the Skin, Tongue and Esophagus. | Dermatopathology (Basel) | 2023 | 37366801 | PubTator, text mining | PubMed |
| Species delimitation, biogeography, and natural history of dwarf funnel web spiders (Mygalomorphae, Hexurellidae, Hexurella) from the United States / Mexico borderlands. | Zookeys | 2023 | 37363739 | PubTator, text mining | PubMed |
| A Review on Saliva-Based Health Diagnostics: Biomarker Selection and Future Directions. | Biomed Mater Devices | 2023 | 37363139 | PubTator, text mining | PubMed |
| Experimental and computational insights into the mechanism of the copper(i)-catalysed sulfonylative Suzuki-Miyaura reaction. | Chem Sci | 2023 | 37350817 | PubTator, text mining | PubMed |
| Metformin and cancer hallmarks: shedding new lights on therapeutic repurposing. | J Transl Med | 2023 | 37344841 | PubTator, text mining | PubMed |
| Cathepsins in oral diseases: mechanisms and therapeutic implications. | Front Immunol | 2023 | 37334378 | PubTator, text mining | PubMed |
| 16α-OHE1, a novel oestrogen metabolite, attenuates dysfunction of left ventricle contractility via regulation of autophagy after myocardial ischemia and reperfusion. | Int J Cardiol | 2023 | 37330017 | PubTator, text mining | PubMed |
| The Impact of Genetically Proxied AMPK Activation, the Target of Metformin, on Functional Outcome Following Ischemic Stroke. | J Stroke | 2023 | 37282373 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/537/papers?page=8